Dr. Jin-Hyoung, Kang
Specialty
Lung Cancer, Head and Neck Cancer, Melanoma
Institution
The Catholic University of Korea, Seoul ST. Mary’s Hospital
Education
1978~1984 Graduation from College of Medicine, The Catholic University of Korea 1986~1988 (M.S) The Catholic University of Korea
1991~1995 (M.D., Ph.D.) The Catholic University of Korea
Medical Society Activity
2013 ~ 2014. The Director of Lung Cancer Committee of Korean Cancer Study Group 2015 ~ 2016 The Vice-Chairman of Korean Association of Lung Cancer
2015 ~ Present. The Chairman of Korean Cancer Study Group
Major Publication
2016 Sep CLINICAL LUNG CANCER
Prognostic Impact of Multiple Clinicopathologic Risk Factors and c-MET Overexpression in Patients Who Have Undergone Resection of Stage IB Non–Small-Cell Lung Cancer
2016 Jul CANCER RESEARCH AND TREATMENT
Clinical Characteristics and Continued Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Administration in EGFR-Mutated Non-small Cell Lung Cancer with Skeletal Metastasis
2016 May PATHOLOGY RESEARCH AND PRACTICE
The prognostic role of tissue and serum MMP-1 and TIMP-1 expression in patients with non-small cell lung cancer
2015 Aug JOURNAL OF CLINICAL ONCOLOGY
Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04
2014 Nov LANCET ONCOLOGY
Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial
2014 Sep JOURNAL OF CANCER
Serum Carcinoembryonic antigen levels and the risk of whole-body metastatic potential in advanced nonsmall cell lung cancer
05 月 18 日(周六)上午
08:00-08:20 开场式
08:20-09:50 第一环节:靶向专题一
10:00-11:30 第二环节:靶向专题二
11:50-13:10 第三环节:卫星会
05 月 18 日(周六)下午
13:20-15:20 第四环节:免疫治疗专题一
15:30-17:20 第五环节:免疫治疗专题二